Cargando…

Maternal and neonatal antibody levels on pertussis vaccination in pregnant women on immune-modulating therapy for rheumatic disease

OBJECTIVES: While protection against pertussis following maternal tetanus-diphtheria-and-acellular-pertussis (Tdap) vaccination was demonstrated in healthy term-born infants, no evidence is available on Tdap vaccination in combination with immune-modulating therapy during pregnancy. In this pilot st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghalandari, Nafise, Immink, Maarten M, Röder, Esther, Bruijning-Verhagen, Patricia C J, Smeele, Hieronymus, Crijns, Hubertina, van der Maas, Nicoline A T, Bekker, Mireille N, Sanders, Elisabeth A M, Dolhain, Radboud J E M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462940/ https://www.ncbi.nlm.nih.gov/pubmed/37640516 http://dx.doi.org/10.1136/rmdopen-2023-002985

Ejemplares similares

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
por: Ghalandari, Nafise, et al.
Publicado: (2022)

Active counselling and well-controlled disease result in a higher percentage of women with rheumatoid arthritis that breast feed: results from the PreCARA study
por: Kemper, Erik, et al.
Publicado: (2022)

Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance
por: Ghalandari, Nafise, et al.
Publicado: (2022)

Reported congenital malformations after exposure to non‐tumour necrosis factor inhibitor biologics: A retrospective comparative study in EudraVigilance
por: Ghalandari, Nafise, et al.
Publicado: (2022)

Biological and Methotrexate Survival after Pregnancy in Patients With a Rheumatic Disease
por: Tahmasian, Helena, et al.
Publicado: (2022)

Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants
por: Immink, Maarten M., et al.
Publicado: (2021)

Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study
por: Smeele, Hieronymus TW, et al.
Publicado: (2021)

IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive
por: Bongenaar, Margot, et al.
Publicado: (2020)

Maternal vaccination against pertussis as part of the national immunization program: a qualitative evaluation among obstetric care providers one year after the implementation in December 2019
por: Immink, Maarten M., et al.
Publicado: (2023)

Parenting problems postpartum can be detected early in pregnancy in patients with rheumatoid arthritis
por: Smeele, Hieronymus T W, et al.
Publicado: (2020)

Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients’ offspring
por: Smeele, Hieronymus T W, et al.
Publicado: (2022)

Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply
por: Smeele, Hieronymus T W, et al.
Publicado: (2021)

Low prevalence of anti-SSA (anti-Ro) and anti-SSB (anti-La) autoantibodies in female patients with rheumatoid arthritis with a wish to conceive
por: Smeele, Hieronymus T W, et al.
Publicado: (2021)

Systemic lupus erythematosus and COVID-19 during pregnancy
por: Smeele, Hieronymus TW, et al.
Publicado: (2021)

Reinvestigating the Coughing Rat Model of Pertussis To Understand Bordetella pertussis Pathogenesis
por: Hall, Jesse M., et al.
Publicado: (2021)

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands
por: Versteegen, Pauline, et al.
Publicado: (2021)

Pertussis hospitalizations among term and preterm infants: clinical course and vaccine effectiveness
por: van der Maas, Nicoline A. T., et al.
Publicado: (2019)

Paternal inflammatory arthritis is associated with a higher risk of miscarriage: results of a large multicentre study (iFAME-Fertility)
por: Perez-Garcia, Luis F, et al.
Publicado: (2021)

Exercise, infection and rheumatic diseases: what do we know?
por: Calabrese, Leonard, et al.
Publicado: (2021)

Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
por: Santos, Cristiana Sieiro, et al.
Publicado: (2021)

The Self‐Administered Rheumatoid Arthritis Disease Activity Index (RADAI) is Less Accurate than DAS28‐CRP as a Disease Activity Measure in Pregnancy
por: Smeele, H. T. W., et al.
Publicado: (2019)

Impaired fertility in men diagnosed with inflammatory arthritis: results of a large multicentre study (iFAME-Fertility)
por: Perez-Garcia, Luis Fernando, et al.
Publicado: (2021)

Biological treatment usage in patients with HIV and rheumatic disease, 2003–2021: long-term safety and follow-up
por: Naovarat, Benjamin Sornrung, et al.
Publicado: (2022)

Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study
por: Álvaro Gracia, Jose María, et al.
Publicado: (2021)

Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review
por: Neusser, Silke, et al.
Publicado: (2022)

Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study
por: Andreica, Ioana, et al.
Publicado: (2023)

Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review
por: Ghalandari, N., et al.
Publicado: (2020)

It is not just about sex: viewpoints of men with inflammatory arthritis on the overall impact of the disease on their sexual health
por: Perez-Garcia, Luis Fernando, et al.
Publicado: (2021)

The Potential Role of Subclinical Bordetella pertussis Infection in Epilepsy
por: Rubin, Keith, et al.
Publicado: (2019)

A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains
por: Zurita, María Eugenia, et al.
Publicado: (2019)

Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study
por: Kiltz, Uta, et al.
Publicado: (2021)

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study
por: Boekel, Laura, et al.
Publicado: (2022)

Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
por: Schulze-Koops, Hendrik, et al.
Publicado: (2021)

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases
por: Sieiro Santos, Cristiana, et al.
Publicado: (2022)

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Sattui, Sebastian Eduardo, et al.
Publicado: (2021)

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases
por: Hasseli, Rebecca, et al.
Publicado: (2021)

Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?
por: Laster, Andrew J, et al.
Publicado: (2022)

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases
por: Hasseli, Rebecca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_38dl4p3adgu42q2kl68bkgb8of